BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30640733)

  • 1. Activating Structural Alterations in MAPK Genes Are Distinct Genetic Drivers in a Unique Subgroup Of Spitzoid Neoplasms.
    Quan VL; Zhang B; Mohan LS; Shi K; Isales MC; Panah E; Taxter TJ; Beaubier N; White K; Gerami P
    Am J Surg Pathol; 2019 Apr; 43(4):538-548. PubMed ID: 30640733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spitz melanoma is a distinct subset of spitzoid melanoma.
    Raghavan SS; Peternel S; Mully TW; North JP; Pincus LB; LeBoit PE; McCalmont TH; Bastian BC; Yeh I
    Mod Pathol; 2020 Jun; 33(6):1122-1134. PubMed ID: 31900433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanocytic tumors with MAP3K8 fusions: report of 33 cases with morphological-genetic correlations.
    Houlier A; Pissaloux D; Masse I; Tirode F; Karanian M; Pincus LB; McCalmont TH; LeBoit PE; Bastian BC; Yeh I; de la Fouchardière A
    Mod Pathol; 2020 May; 33(5):846-857. PubMed ID: 31719662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAP2K1-Mutated Melanocytic Neoplasms With a SPARK-Like Morphology.
    Donati M; Nosek D; Waldenbäck P; Martinek P; Jonsson BA; Galgonkova P; Hawawrehova M; Berouskova P; Kastnerova L; Persichetti P; Crescenzi A; Michal M; Kazakov DV
    Am J Dermatopathol; 2021 Jun; 43(6):412-417. PubMed ID: 33264134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Clinicopathological Study of 29 Spitzoid Melanocytic Lesions With ALK Fusions, Including Novel Fusion Variants, Accompanied by Fluorescence In Situ Hybridization Analysis for Chromosomal Copy Number Changes, and Both TERT Promoter and Next-Generation Sequencing Mutation Analysis.
    Kastnerova L; Martinek P; Grossmann P; Steiner P; Vanecek T; Kyclova J; Ferak I; Zalud R; Slehobr O; Svajdler P; Sulc M; Bradamante M; Banik M; Hadravsky L; Sticova E; Hajkova V; Ptakova N; Michal M; Kazakov DV
    Am J Dermatopathol; 2020 Aug; 42(8):578-592. PubMed ID: 32701692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of Morphologic and Molecular Features of BRAF, ALK, and NTRK1 Fusion Spitzoid Neoplasms.
    Amin SM; Haugh AM; Lee CY; Zhang B; Bubley JA; Merkel EA; Verzì AE; Gerami P
    Am J Surg Pathol; 2017 Apr; 41(4):491-498. PubMed ID: 27776007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of ALK gene alterations among the spectrum of plexiform spitzoid lesions.
    Saraggi D; Salmaso R; Zamuner C; Munari G; Lanza C; Alaibac MS; Bassetto F; Rugge M; Montesco MC; Cerroni L; Fassan M
    J Am Acad Dermatol; 2018 Oct; 79(4):728-735. PubMed ID: 29920315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic similarities between Spitz nevus and Spitzoid melanoma in children.
    Gill M; Cohen J; Renwick N; Mones JM; Silvers DN; Celebi JT
    Cancer; 2004 Dec; 101(11):2636-40. PubMed ID: 15503312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating Next-Generation Sequencing with Morphology Improves Prognostic and Biologic Classification of Spitz Neoplasms.
    Quan VL; Zhang B; Zhang Y; Mohan LS; Shi K; Wagner A; Kruse L; Taxter T; Beaubier N; White K; Zou L; Gerami P
    J Invest Dermatol; 2020 Aug; 140(8):1599-1608. PubMed ID: 32004563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
    Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
    Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis.
    Massi D; Cesinaro AM; Tomasini C; Paglierani M; Bettelli S; Dal Maso L; Simi L; Salvianti F; Pinzani P; Orlando C; De Giorgi V; Lukic S; Maiorana A; Santucci M; Canzonieri V
    J Am Acad Dermatol; 2011 May; 64(5):919-35. PubMed ID: 21496703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spitz Tumors With ROS1 Fusions: A Clinicopathological Study of 6 Cases, Including FISH for Chromosomal Copy Number Alterations and Mutation Analysis Using Next-Generation Sequencing.
    Donati M; Kastnerova L; Martinek P; Grossmann P; Sticová E; Hadravský L; Torday T; Kyclova J; Michal M; Kazakov DV
    Am J Dermatopathol; 2020 Feb; 42(2):92-102. PubMed ID: 31361613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copy number variations and clinical outcome in atypical spitz tumors.
    Raskin L; Ludgate M; Iyer RK; Ackley TE; Bradford CR; Johnson TM; Fullen DR
    Am J Surg Pathol; 2011 Feb; 35(2):243-52. PubMed ID: 21263245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of gene fusions in melanocytic neoplasms.
    Quan VL; Panah E; Zhang B; Shi K; Mohan LS; Gerami P
    J Cutan Pathol; 2019 Nov; 46(11):878-887. PubMed ID: 31152596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pathologic findings of Spitz nevi and atypical Spitz tumors with ALK fusions.
    Busam KJ; Kutzner H; Cerroni L; Wiesner T
    Am J Surg Pathol; 2014 Jul; 38(7):925-33. PubMed ID: 24698967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanocytic Neoplasms With MAP2K1 in Frame Deletions and Spitz Morphology.
    Sunshine JC; Kim D; Zhang B; Compres EV; Khan AU; Busam KJ; Gerami P
    Am J Dermatopathol; 2020 Dec; 42(12):923-931. PubMed ID: 33289976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward a Molecular-Genetic Classification of Spitzoid Neoplasms.
    Tetzlaff MT; Reuben A; Billings SD; Prieto VG; Curry JL
    Clin Lab Med; 2017 Sep; 37(3):431-448. PubMed ID: 28802494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, histopathologic, and genomic features of Spitz tumors with ALK fusions.
    Yeh I; de la Fouchardiere A; Pissaloux D; Mully TW; Garrido MC; Vemula SS; Busam KJ; LeBoit PE; McCalmont TH; Bastian BC
    Am J Surg Pathol; 2015 May; 39(5):581-91. PubMed ID: 25602801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restrospective reappraisal of the prognostic classification of spitzoid melanocytic neoplasms after BRAF and NRAS mutation characterisation: a single institution experience.
    Moysset I; Castrejon N; Garcia-Herrera A; Castillo P; Marginet M; Teixido C; Podlipnik S; Albero-Gonzalez R; Montironi C; Navarro J; Rovira C; Puig S; Carrera C; Alos L
    Histopathology; 2024 Jun; 84(7):1154-1166. PubMed ID: 38409889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Giant lung metastasis of NRAS-mutant melanoma in a 24-year-old patient with a history of BRAF-mutant conventional melanoma harboring Spitzoid morphology: a case report.
    Vachtenheim J; Kodet R; Fischer O; Kolek V; Strizova Z; Ozaniak A; Simonek J; Stolz A; Pozniak J; Kolarik J; Svorcova M; Vachtenheim J; Lischke R
    Diagn Pathol; 2020 Oct; 15(1):132. PubMed ID: 33100226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.